Microbiome science merges with oncology for better cancer treatments
Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to…
Enhancing brain tumor detection through deep learning and explainable AI techniques
This section provides a comprehensive description of the proposed DL framework for brain tumor detection in MRI scans.…
Blood test may predict which colorectal cancer patients benefit from chemotherapy
A blood test may help identify which patients with colorectal cancer that has spread to the liver are…
AstraZeneca (LSE:AZN) Wins Two EU Cancer Approvals And Starts Abbisko Lung Trial
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
Targeted therapy doubles progression-free survival in rare bile duct cancer
Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid…
CAR-T cell therapy shows potential to eliminate aggressive glioblastoma
A study led by a researcher based at King’s College London and McMaster University in Canada reveals how…
Cancer’s biggest treatment challenge may be getting solved 250 miles above Earth
For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies…
City of Hope Develops Blood Test for Early Colorectal Cancer Detection
City of Hope is developing a blood test designed to detect colorectal cancer early, targeting a rising incidence…
Baseline plasma-informed circulating tumor DNA analyses comparing multiplex digital PCR and NGS for longitudinal monitoring in Hodgkin lymphoma
Despite excellent cure rates in Hodgkin lymphoma (HL) [1], 10–15% of patients experience primary treatment failure or long-term…
Mom’s ‘disjointed speech’ dismissed as menopause was brain cancer | Health
(Brain Tumour Research via SWNS) By Alexandra Snow A mom’s “confused and disjointed” speech was dismissed as menopausal…
Revolution Medicines to Present Clinical Data from RAS(ON)
REDWOOD CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, a late-stage clinical oncology company developing targeted…
Engineered CAR-T cells offer potential rheumatoid arthritis cure
For the 18 million people living with rheumatoid arthritis, disease management currently means a lifetime of injections-a reality…